Differences in gastric carcinoma microenvironment stratify according to EBV infection intensity; implications for possible immune adjuvant therapy

SRP019961

Homo sapiens

2 Downloadable Samples

Illumina HiSeq 2000

Submitter Supplied Information

Description

Our goal of this study was to perform quantitative and global assessment of EBV gene expression in gastric carcinomas and assess EBV associated cellular pathway alterations. Overall design: Examination of a gastric carcinoma cell line naturally infected with EBV, SNU-719 using poly-A and ribodepletion RNA-seq data sets

PubMed ID

26178981

Publication Title

Latent Expression of the Epstein-Barr Virus (EBV)-Encoded Major Histocompatibility Complex Class I TAP Inhibitor, BNLF2a, in EBV-Positive Gastric Carcinomas.

Total Samples

Submitter’s Institution

No associated institution

Authors

Strong MJ, Laskow T, Nakhoul H, Blanchard E, Liu Y, Wang X, Baddoo M, Lin Z, Yin Q, Flemington EK

Source Repository

Sequence Read Archive (SRA)

Alternate Accession IDs

GSE45453

No rows found